ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA)

CUSIP: 000899104

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+14,291,620
Put/Call ratio
66%
SEC-reported price per share
$1.98
Number of holders
106
Value change
+$28,768,170
Number of buys
62
Open additional details 1 more signal available
Number of sells
52
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
231,297,595

Security key

000899104

Report period

Q2 2022

Institutions

106

Top holders

10

Ownership snapshot

Top reported holders of ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5 13F Highest disclosed value: $59,945,935 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $59.95M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $59.95M
BOOTHBAY FUND MANAGEMENT, LLC $19.05M
VANGUARD GROUP INC $14.89M
Stonepine Capital Management, LLC $13.05M
Magnetar Financial LLC $11.91M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$59,945,935
13,262,375 shares
— 28 Sep 2021
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$19,047,000
10,408,259 shares
— 31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$14,893,000
8,138,420 shares
— 31 Mar 2022
Stonepine Capital Management, LLC
13F
Company
13F
—
denominator unverified
$13,051,000
7,131,808 shares
— 31 Mar 2022
Magnetar Financial LLC
13F
Company
13F
—
denominator unverified
$11,911,000
6,508,917 shares
— 31 Mar 2022
Nuveen Asset Management, LLC
13F
Company
13F
—
denominator unverified
$11,848,000
7,594,940 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
106
Shares
119,212,509
Rows available
106
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
101
Q2 2022 holders
106
Holder diff
5
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .